Henry Waxman

Henry Waxman, born on September twelfth, nineteen thirty-nine, is a distinguished American politician and lawyer who served as a U.S. representative from California for four decades, from nineteen seventy-five to twenty-fifteen. A prominent member of the Democratic Party, his congressional district encompassed much of the western part of Los Angeles, including West Hollywood, Santa Monica, and Beverly Hills. Throughout his tenure, he represented the twenty-fourth district from nineteen seventy-five to nineteen ninety-three, the twenty-ninth district from nineteen ninety-three to two thousand three, and the thirtieth district from two thousand three to two thousand thirteen, adapting to changes brought about by redistricting after the censuses of nineteen ninety, two thousand, and two thousand ten.

Waxman was known for his influential role as a liberal member of Congress, championing significant legislation that shaped public policy. His legislative achievements include the Infant Formula Act of nineteen eighty, the Orphan Drug Act of nineteen eighty-three, and the Drug Price Competition and Patent Term Restoration Act of nineteen eighty-four. He also played a crucial role in the passage of the Clean Air Act of nineteen ninety, the Ryan White CARE Act of nineteen ninety, and the Food Quality Protection Act of nineteen ninety-six, among others.

In nineteen eighty-five, Waxman notably influenced the decision to ban federal funding for the Red Line subway in Los Angeles, ensuring that it would not extend into his affluent Westside district. His commitment to public health and welfare continued with the establishment of the State Children's Health Insurance Program in nineteen ninety-seven and the Patient Protection and Affordable Care Act in two thousand ten.

After leaving Congress, Waxman transitioned to a new role as chairman of Waxman Strategies, a lobbying firm based in Washington, D.C. He also shares his expertise as a Regent Lecturer at the University of California, Los Angeles, and as a lecturer at the Johns Hopkins Bloomberg School of Public Health, continuing to influence policy and educate future leaders.